SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
about
Paeonol attenuates aging MRC-5 cells and inhibits epithelial-mesenchymal transition of premalignant HaCaT cells induced by aging MRC-5 cell-conditioned medium.Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway.SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target
P2860
SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
SOSTDC1 inhibits follicular th ...... d MAPK/Erk signaling pathways.
@en
type
label
SOSTDC1 inhibits follicular th ...... d MAPK/Erk signaling pathways.
@en
prefLabel
SOSTDC1 inhibits follicular th ...... d MAPK/Erk signaling pathways.
@en
P2093
P2860
P1476
SOSTDC1 inhibits follicular th ...... nd MAPK/Erk signaling pathways
@en
P2093
Jialin Feng
Qinyi Zhou
Wenjie Zheng
P2860
P2888
P356
10.1007/S11010-017-3059-0
P50
P577
2017-05-27T00:00:00Z
P6179
1085613180